CDISC adds Karen Curran, Brooke Hinkson and Lisa Lin to its Board of Directors

– USA, TX –  CDISC today announced the additions of Karen Curran, Brooke Hinkson, and Lisa Lin to its Board of Directors.

“It is a pleasure to welcome these gifted leaders to our Board. Their expertise and insight will positively impact CDISC as we continue to focus on standards implementation and standards automation to drive clinical research forward,” said CEO, David Evans.

Other Board Members include:

  • Chair Pam Howard, ICON;
  • Chair-Elect Dr. Erik Pulkstenis, AbbVie;
  • Past Chair Margaret Keegan, Linden Capital Partners;
  • Dr. Wenjun Bao, JMP Life Sciences of SAS Institute Inc.;
  • Chris Decker, d-Wise;
  • Dr. David Hardison;
  • Dr. Pandu Kulkarni, Eli Lilly;
  • Dr. Hiroshi Masumoto, Daiichi Sankyo;
  • Dr. Mihoko Okada, Institute of Health Data Infrastructure for All;
  • Dr. Christina Reith, University of Oxford’s Nuffield Department of Population Health;
  • Steve Rosenberg, uMotif;
  • non-voting CDISC Advisory Council Chair Jonathan Chainey, Roche;
  • ex-officio, David Evans, CDISC.

About Karen Curran

Karen Curran is VP, Global Strategic Partnerships at IQVIA where she provides strategic direction and guidance on building and optimizing processes and outsourcing strategies for sponsors that result in successful long-term partnerships. An early CDISC adopter, Karen has over 25 years of experience with clinical research organizations, leading global teams across Standards & Innovation, Data Management, Statistics, Statistical Programming, and Medical Writing.

About Brooke Hinkson

Brooke Hinkson is the Executive Director, Global Clinical Data Standards at Merck & Co., Inc., Kenilworth, NJ, the USA in support of enabling process optimization, technology-enabled information management, and compliance with regulation and guidance for clinical study data. She has over 25 years of experience defining clinical data standards strategies and standards operating models to support the adoption, definition, use, sharing, and governance of standards.

About Lisa Lin

Lisa Lin is a Study Data Standards Manager at FDA CBER (Center for Biologics Evaluation and Research), currently responsible for all study data standards projects, including study data validation, evaluation, and testing of the SEND standard, data standards, and analysis tool training, and support for CBER reviewers. Previously, Lisa worked at CDER (Center of Drug Evaluation and Research) as a Data Standards Lead where she played an important role in leading study data standards development and implementation.

About CDISC

CDISC creates clarity in clinical research by convening a global community to develop and advance data standards of the highest quality. Required by the United States Food and Drug Administration and Japan’s Pharmaceuticals and Medical Devices Agency, recommended by the China National Medical Products Administration and adopted by the world’s leading research organizations, CDISC standards enable accessibility, interoperability, and reusability of data. With the help of CDISC standards, the entire research community can maximize the value of data for more efficient and meaningful research that has an invaluable impact on global health. CDISC is a 501(c)(3) global nonprofit charitable organization and is headquartered in Austin, Texas, with hundreds of employees, volunteers, and member organizations around the world.

For more information: https://www.cdisc.org/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.